Letters |

Conventional and High-Dose Radiation in Treating Early Prostate Cancer—Reply

James A. Talcott, MD, SM; Anthony L. Zietman, MD
JAMA. 2010;304(2):155-156. doi:10.1001/jama.2010.928.
Text Size: A A A
Published online


In Reply: As Dr Vikram notes, the 9-Gy–higher radiation dose in PROG 9509 has not produced a survival benefit despite halving biochemical, or prostate-specific antigen, progression.1,2 Given the association between progression-free survival and overall survival, an overall survival benefit from the higher dose may emerge. However, such an advantage will be delayed by the relatively indolent natural history of prostate cancer and attenuated by competing mortality, given the 76-year median age of surveyed men. Both effects were seen in the Scandinavian randomized trial of surgery vs observation for early prostate cancer.3 We do believe that finding no outcome differences between study groups using a sensitive, treatment-specific survey instrument is stronger evidence of similar long-term outcomes than the comment that patients “stopped complaining” suggests.


Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview




July 14, 2010
Bhadrasain Vikram, MD
JAMA. 2010;304(2):155-156. doi:10.1001/jama.2010.927.
July 14, 2010
Boris Pasche, MD, PhD; Robert A. McNutt, MD; Phil B. Fontanarosa, MD, MBA
JAMA. 2010;304(2):155-156. doi:10.1001/jama.2010.929.
Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).


Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.